v3.26.3
Income Tax - Schedule of components of the Company's deferred tax assets for federal income taxes (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carryforwards $ 1,355,370 $ 261,570
Accruals and other 246,023 64,374
Capitalized research and development expenditures 19,853 25,528
Research and development tax credits 124,886 6,606
Lease liabilities 40,967  
Share-based compensation 11,706  
Total deferred tax assets 1,798,804 358,078
Less: valuation allowance (1,759,255) $ (358,078)
Deferred tax asset, net of valuation allowance 39,548  
Deferred tax liabilities:    
Depreciation and amortization (2,983)  
Right-of-use assets (36,565)  
Total deferred tax liabilities $ (39,548)